Identification of a Mutation Associated with Fatal Foal Immunodeficiency Syndrome in the Fell and Dales Pony
The Fell and Dales are rare native UK pony breeds at risk due to falling numbers, in-breeding, and inherited disease. Specifically, the lethal Mendelian recessive disease Foal Immunodeficiency Syndrome (FIS), which manifests as B-lymphocyte immunodeficiency and progressive anemia, is a substantial threat. A significant percentage (∼10%) of the Fell ponies born each year dies from FIS, compromising the long-term survival of this breed. Moreover, the likely spread of FIS into other breeds is of major concern. Indeed, FIS was identified in the Dales pony, a related breed, during the course of this work. Using a stepwise approach comprising linkage and homozygosity mapping followed by haplotype analysis, we mapped the mutation using 14 FIS–affected, 17 obligate carriers, and 10 adults of unknown carrier status to a ∼1 Mb region (29.8 – 30.8 Mb) on chromosome (ECA) 26. A subsequent genome-wide association study identified two SNPs on ECA26 that showed genome-wide significance after Bonferroni correction for multiple testing: BIEC2-692674 at 29.804 Mb and BIEC2-693138 at 32.19 Mb. The associated region spanned 2.6 Mb from ∼29.6 Mb to 32.2 Mb on ECA26. Re-sequencing of this region identified a mutation in the sodium/myo-inositol cotransporter gene (SLC5A3); this causes a P446L substitution in the protein. This gene plays a crucial role in the regulatory response to osmotic stress that is essential in many tissues including lymphoid tissues and during early embryonic development. We propose that the amino acid substitution we identify here alters the function of SLC5A3, leading to erythropoiesis failure and compromise of the immune system. FIS is of significant biological interest as it is unique and is caused by a gene not previously associated with a mammalian disease. Having identified the associated gene, we are now able to eradicate FIS from equine populations by informed selective breeding.
Vyšlo v časopise:
Identification of a Mutation Associated with Fatal Foal Immunodeficiency Syndrome in the Fell and Dales Pony. PLoS Genet 7(7): e32767. doi:10.1371/journal.pgen.1002133
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pgen.1002133
Souhrn
The Fell and Dales are rare native UK pony breeds at risk due to falling numbers, in-breeding, and inherited disease. Specifically, the lethal Mendelian recessive disease Foal Immunodeficiency Syndrome (FIS), which manifests as B-lymphocyte immunodeficiency and progressive anemia, is a substantial threat. A significant percentage (∼10%) of the Fell ponies born each year dies from FIS, compromising the long-term survival of this breed. Moreover, the likely spread of FIS into other breeds is of major concern. Indeed, FIS was identified in the Dales pony, a related breed, during the course of this work. Using a stepwise approach comprising linkage and homozygosity mapping followed by haplotype analysis, we mapped the mutation using 14 FIS–affected, 17 obligate carriers, and 10 adults of unknown carrier status to a ∼1 Mb region (29.8 – 30.8 Mb) on chromosome (ECA) 26. A subsequent genome-wide association study identified two SNPs on ECA26 that showed genome-wide significance after Bonferroni correction for multiple testing: BIEC2-692674 at 29.804 Mb and BIEC2-693138 at 32.19 Mb. The associated region spanned 2.6 Mb from ∼29.6 Mb to 32.2 Mb on ECA26. Re-sequencing of this region identified a mutation in the sodium/myo-inositol cotransporter gene (SLC5A3); this causes a P446L substitution in the protein. This gene plays a crucial role in the regulatory response to osmotic stress that is essential in many tissues including lymphoid tissues and during early embryonic development. We propose that the amino acid substitution we identify here alters the function of SLC5A3, leading to erythropoiesis failure and compromise of the immune system. FIS is of significant biological interest as it is unique and is caused by a gene not previously associated with a mammalian disease. Having identified the associated gene, we are now able to eradicate FIS from equine populations by informed selective breeding.
Zdroje
1. ScholesSFHollimanAMayPDHolmesMA 1998 A syndrome of anemia, immunodeficiency and peripheral ganglionopathy in Fell pony foals. Vet Rec 142 6 128 34
2. ThomasGWBellSCPhythianCTaylorPKnottenbeltDC 2003 Aid to the antemortem diagnosis of Fell pony foal syndrome by the analysis of B lymphocytes. Vet Rec 152 20 618 21
3. ThomasGWBellSCCarterSD 2005 Immunoglobulin and peripheral B-lymphocyte concentrations in Fell pony foal syndrome. Equine Vet J 37 1 48 52
4. BellSCSavidgeCTaylorPKnottenbeltDCCarterSD 2001 An immunodeficiency in Fell ponies: a preliminary study into cellular responses. Equine Vet J 33 7 687 92
5. DixonJBSavageMWattretATaylorPRossG 2000 Discriminant and multiple regression analysis of anemia and opportunistic infection in Fell pony foals. Vet Clin Pathol 29 3 84 86
6. Fox-ClipshamLSwinburneJEPapoula-PereiraRIBlundenASMalalanaF 2009 Immunodeficiency/anemia syndrome in a Dales pony. Vet Rec 165 10 289 90
7. ThomasGW 2003 Immunodeficiency in Fell Ponies. PhD thesis:University of Liverpool
8. ShinEKPerrymanLEMeekK 1997 A kinase-negative mutation of DNA-PK(CS) in equine SCID results in defective coding and signal joint formation. J Immunol 158 8 3565 9
9. WilerRLeberRMooreBBVanDykLFPerrymanLE 1995 Equine severe combined immunodeficiency: a defect in V(D)J recombination and DNA-dependent protein kinase activity. Proc Natl Acad Sci U S A 92 25 11485 9
10. McGuireTCBanksKLDavisWC 1976 Alterations of the thymus and other lymphoid tissue in young horses with combined immunodeficiency. Am J Pathol 84 1 39 54
11. PerrymanLE 2000 Primary immunodeficiencies of horses. Vet Clin North Am Equine Pract 16 1 105 16 vii
12. FahamSWatanabeABessererGMCascioDSpechtA 2008 The crystal structure of a sodium galactose transporter reveals mechanistic insights into Na+/sugar symport. Science 321 5890 810 4
13. WatanabeAChoeSChaptalVRosenbergJMWrightEM 2010 The mechanism of sodium and substrate release from the binding pocket of vSGLT. Nature 468 7326 988 91
14. BrandlCJDeberCM 1986 Hypothesis about the function of membrane-buried proline residues in transport proteins. Proc Natl Acad Sci U S A 83 4 917 21
15. VilsenBAndersenJPClarkeDMMacLennanDH 1989 Functional consequences of proline mutations in the cytoplasmic and transmembrane sectors of the Ca2(+)-ATPase of sarcoplasmic reticulum. J Biol Chem 264 35 21024 30
16. HaussingerD 1996 The role of cellular hydration in the regulation of cell function. Biochem J 313 ( Pt 3) 697 710
17. KinoTTakatoriHManoliIWangYTiulpakovA 2009 Brx mediates the response of lymphocytes to osmotic stress through the activation of NFAT5. Sci Signal 2 57 ra5
18. GoWYLiuXRotiMALiuFHoSN 2004 NFAT5/TonEBP mutant mice define osmotic stress as a critical feature of the lymphoid microenvironment. Proc Natl Acad Sci U S A 101 29 10673 8
19. KinoTSegarsJHChrousosGP 2010 Brx, a link between osmotic stress, inflammation and organ physiology/pathophysiology. Expert Rev Endocrinol. Metab 5 4 603 614
20. BurgMBFerrarisJDDmitrievaNI 2007 Cellular response to hyperosmotic stresses. Physiol Rev 87 4 1441 74
21. TramaJGoWYHoSN 2002 The osmoprotective function of the NFAT5 transcription factor in T cell development and activation. J Immunol 169 10 5477 88
22. MoranchoBMinguillonJMolkentinJDLopez-RodriguezCAramburuJ 2008 Analysis of the transcriptional activity of endogenous NFAT5 in primary cells using transgenic NFAT-luciferase reporter mice. BMC Mol Biol 9 13
23. RichardsAJKellyDFKnottenbeltDCCheesemanMTDixonJB 2000 Anemia, diarrhoea and opportunistic infections in Fell ponies. Equine Vet J 32 5 386 91
24. BerryGTWangZJDrehaSFFinucaneBMZimmermanRA 1999 In vivo brain myo-inositol levels in children with Down syndrome. J Pediatr 135 1 94 7
25. BerryGTWuSBuccafuscaRRenJGonzalesLW 2003 Loss of murine Na+/myo-inositol cotransporter leads to brain myo-inositol depletion and central apnea. J Biol Chem 278 20 18297 302
26. ChauJFLeeMKLawJWChungSKChungSS 2005 Sodium/myo-inositol cotransporter-1 is essential for the development and function of the peripheral nerves. FASEB J 19 13 1887 9
27. SchuelkeM 2000 An economic method for the fluorescent labeling of PCR fragments. Nat Biotechnol 18 2 233 4
28. SilbersteinMTzemachADovgolevskyNFishelsonMSchusterA 2006 Online system for faster multipoint linkage analysis via parallel execution on thousands of personal computers. Am J Hum Genet 78 6 922 35
29. ExcoffierLLavalGSchneiderS 2005 Arlequin (version 3.0): an integrated software package for population genetics data analysis. Evol Bioinform Online 1 47 50
30. PurcellSNealeBTodd-BrownKThomasLFerreiraMA 2007 PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81 3 559 75
31. StadenRBealKFBonfieldJK 2000 The Staden package, 1998. Methods Mol Biol 132 115 30
32. CarverTJRutherfordKMBerrimanMRajandreamMABarrellBG 2005 ACT: the Artemis Comparison Tool. Bioinformatics 21 16 3422 3
Štítky
Genetika Reprodukčná medicínaČlánok vyšiel v časopise
PLOS Genetics
2011 Číslo 7
- Je „freeze-all“ pro všechny? Odborníci na fertilitu diskutovali na virtuálním summitu
- Gynekologové a odborníci na reprodukční medicínu se sejdou na prvním virtuálním summitu
Najčítanejšie v tomto čísle
- Loss of the BMP Antagonist, SMOC-1, Causes Ophthalmo-Acromelic (Waardenburg Anophthalmia) Syndrome in Humans and Mice
- Genome-Wide Association Study Identifies Novel Restless Legs Syndrome Susceptibility Loci on 2p14 and 16q12.1
- Gene-Based Tests of Association
- Genome-Wide Association Study Identifies as a Susceptibility Gene for Pediatric Asthma in Asian Populations